查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565977

曲安西龍軟膏氟氯化碳市場 - 全球規模、佔有率、趨勢分析、機會、預測，2019-2030

Triamcinolone Ointment Chlorofluorocarbons Market, By Type; By Fuel Type; By Capacity; By Technology; By End User; By Country, Global Trend Analysis, Competitive Landscape & Forecast, 2019-2030
出版日期: | 出版商: Blueweave Consulting | 英文 650 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球氟氯化碳曲安西龍軟膏市場規模將以複合年成長率3.10%擴大，到2030年將達到3.2893億美元

由於皮膚病的增加、對皮質類固醇治療的需求、局部製劑的進步以及醫療保健機會的擴大，氟氯化碳曲安西龍軟膏的全球市場正在成長。

根據領先的策略諮詢和市場研究公司BlueWeave Consulting的最新研究，以金額為準2023年全球氟氯化碳曲安奈德軟膏市場規模為2.6745億美元。 BlueWeave預測，在2024-2030年預測期內，全球氟氯化碳曲安西龍軟膏市場規模將以3.10%的複合年成長率擴大，到2030年將達到3.2893億美元。由於皮膚病的增加、老年人群的意識以及藥物配方的進步，全球曲安西龍軟膏氟氯化碳(CFC) 市場正在迅速擴大。然而，由於環境問題和監管限制，人們開始轉向非 CFC 替代品。有競爭力的定價策略和不斷擴大的分銷網路進一步推動了市場成長。

機會 - 開發不含 CFC 的替代品

由於嚴格的環境法規，全球曲安西龍軟膏市場正在轉向不含氟氯化碳的替代品。製藥公司正在轉向氫氟烷烴和氫氟烯烴等永續推進劑，使其產品更安全、更具吸引力。這種轉變正在推動市場成長，並為曲安西龍軟膏市場的創新和擴張帶來新的機會。

地緣政治緊張局勢加劇對全球曲安西龍軟膏氟氯化碳市場的影響

地緣政治緊張局勢升級可能會嚴重影響全球曲安西龍軟膏氟氯化碳（CFC）市場，導致供應鏈中斷、生產成本增加和價格波動。貿易限制、關稅和製裁可能會使國際貿易複雜化並減少需求。由於其消耗臭氧層特性而收緊法規可能會加速含氟氯化碳產品的逐步使用。國防支出的增加可能會轉移醫療保健資源，進而影響市場成長。

曲安西龍軟膏全球氟氯化碳市場

曲安西龍軟膏全球氟氯化碳市場－按分銷管道

依分銷管道分類，全球氯氟曲安西氟氯化碳軟膏市場分為醫院藥房、零售藥房、網路藥房等細分市場。醫院藥局部門是全球最大的曲安西龍軟膏氟氯化碳市場。此細分市場的主導地位是由於醫院對曲安奈德軟膏的需求量很大，而這些藥物通常用於治療各種皮膚病。醫院藥房可以輕鬆獲得這些藥物，並提供即時獲取和專家指導。此外，醫院藥房的高可靠性和到醫院就診的患者數量的增加也是市場佔有率的因素。

競爭格局

全球氟氯化碳曲安西龍軟膏市場競爭激烈，許多企業爭奪市場佔有率。市場主要企業包括 Akorn Inc.、Cosette Pharmaceuticals Inc.、Glenmark Pharmaceuticals、Bristol Myers Squibb Company、Lupin Limited、Novartis International AG、Sun Pharmaceutical Industries Limited、Mylan NV、Taro Pharmaceutical Industries、Lotus International、Delcor 公司，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation，包括Fougera Corporation (Sandoz AG)、Perrigo Company plc 等主要企業。這些公司正在增加對研發活動、合併、收購、合資、聯盟、授權合約、新產品和服務發布等的投資，以利用不同的策略進一步鞏固其在全球曲安西龍氟氯化碳市場的地位。

該報告的詳細分析提供了有關全球曲安西龍軟膏氟氯化碳市場的成長潛力、未來趨勢和統計資料。我們也研究了推動市場總規模預測的因素。該報告致力於提供全球曲安西龍軟膏氟氯化碳市場的最新技術趨勢以及產業見解，以幫助決策者做出策略決策。此外，我們也分析了市場的成長動力、挑戰和競爭力。

目錄

第1章 研究框架

第 2 章執行摘要

第3章全球曲安西龍軟膏氟氯化碳市場洞察

  • 產業價值鏈分析
  • DROC分析
    • 生長促進因子
      • 治療皮膚病的功效
      • 症狀快速緩解
      • 提高可用性和可訪問性
    • 抑制因素
      • 環境問題
      • 監管限制
      • 健康問題
    • 機會
      • 開發不含 CFC 的替代品
      • 藥物輸送系統的創新
    • 任務
      • 開發有效的不含氟氯化碳的替代品
      • 滿足監管要求
  • 科技進步/最新趨勢
  • 法律規範
  • 波特五力分析

第4章全球曲安西龍軟膏氟氯化碳市場：行銷策略

第5章全球曲安西龍軟膏氟氯化碳市場概況

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
      • 曲安奈德軟膏
      • 曲安奈德軟膏
      • 醋酸三安西諾軟膏
      • 曲安奈德氟氯化碳(CFC) 推進劑
      • 其他
    • 按用途
      • 濕疹
      • 皮膚炎
      • 過敏
      • 乾癬
      • 皮疹
      • 其他
    • 按分銷管道
      • 醫院藥房
      • 零售藥房
      • 網路藥房
      • 其他
    • 按地區
      • 北美洲
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲（中東/非洲）

第6章 北美曲安西龍軟膏氟氯化碳市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按用途
    • 按分銷管道
    • 按國家/地區
      • 美國
      • 加拿大

第7章歐洲曲安西龍軟膏氟氯化碳市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按用途
    • 按分銷管道
    • 按國家/地區
      • 德國
      • 英國
      • 義大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 其他歐洲國家

第8章亞太地區曲安西龍軟膏氟氯化碳市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按用途
    • 按分銷管道
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳洲和紐西蘭
      • 印尼
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區其他國家

第9章 拉丁美洲曲安西龍軟膏氟氯化碳市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按用途
    • 按分銷管道
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其他拉丁美洲

第10章中東及非洲曲安西龍軟膏氟氯化碳市場

  • 2019-2030年市場規模及預測
    • 按金額
  • 市場佔有率及預測
    • 按類型
    • 按用途
    • 按分銷管道
    • 按國家/地區
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 科威特
      • 南非
      • 奈及利亞
      • 阿爾及利亞
      • 中東和非洲其他地區

第11章競爭格局

  • 主要參與者及其產品列表
  • 2023年氟氯化碳曲安西龍軟膏全球市場佔有率分析
  • 透過管理參數進行競爭基準基準化分析
  • 重大策略發展（合併、收購、聯盟等）

第12章 地緣政治緊張局勢升級對全球曲安西龍軟膏氟氯化碳市場的影響

第13章 公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人員、主要競爭對手、聯絡方式、策略展望、SWOT分析）

  • Akorn Inc.
  • Cosette Pharmaceuticals Inc.
  • Glenmark Pharmaceuticals
  • Bristol Myers Squibb Company
  • Lupin Limited
  • Novartis International AG
  • Sun Pharmaceutical Industries Limited
  • Mylan NV
  • Taro Pharmaceutical Industries
  • Lotus International
  • Delcor Asset Corporation
  • Fougera（Sandoz AG）
  • Perrigo Company plc
  • 其他主要企業

第14章 主要策略建議

第15章調查方法

簡介目錄
Product Code: BWC24655

Global Triamcinolone Ointment Chlorofluorocarbons Market Size Expands at a Significant CAGR of 3.10% To Touch USD 328.93 Million by 2030

Global Triamcinolone Ointment Chlorofluorocarbons Market is thriving due to rising skin conditions, demand for corticosteroid treatments, advancements in topical formulations, and expanding healthcare access.

BlueWeave Consulting, a leading strategic consulting, and Market research firm, in its recent study, estimated Global Triamcinolone Ointment Chlorofluorocarbons Market size by value at USD 267.45 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Global Triamcinolone Ointment Chlorofluorocarbons Market size to expand at a CAGR of 3.10% reaching a value of USD 328.93 million in 2030. Global Triamcinolone Ointment Chlorofluorocarbons (CFCs) Market is expanding rapidly owing to rising skin conditions, geriatric population awareness, and advancements in pharmaceutical formulations. However, environmental concerns and regulatory restrictions have led to a shift towards non-CFC alternatives. The market's growth is further fueled by competitive pricing strategies and an expanding distribution network.

Opportunity - Development of CFC-Free Alternatives

Global Triamcinolone Ointment Market is shifting towards CFC-free alternatives due to strict environmental regulations. Pharmaceutical companies are focusing on sustainable propellants like hydrofluoroalkanes and hydrofluoroolefins, enhancing product safety and appeal. This shift is driving market growth and opening new opportunities for innovation and expansion in the triamcinolone ointment market.

Impact of Escalating Geopolitical Tensions on Global Triamcinolone Ointment Chlorofluorocarbons Market

Escalating geopolitical tensions could significantly impact Global Triamcinolone Ointment Chlorofluorocarbons (CFCs) Market, leading to supply chain disruptions, increased production costs, and price volatility. Trade restrictions, tariffs, and sanctions could complicate international trade and reduce demand. Stricter regulations due to ozone-depleting properties could accelerate the phasing out of CFC-containing products. Increased defense spending could divert resources from healthcare, affecting market growth.

Global Triamcinolone Ointment Chlorofluorocarbons Market

Global Triamcinolone Ointment Chlorofluorocarbons Market - By Distribution Channel

By distribution channel, Global Triamcinolone Ointment Chlorofluorocarbons Market is divided into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others segments. Hospital pharmacies segment is the largest in Global Triamcinolone Ointment Chlorofluorocarbons Market. The segment dominance is due to the high demand for triamcinolone ointments in hospitals, where these medications are commonly prescribed for managing various skin conditions. Hospital pharmacies provide easy access to these medications, ensuring immediate availability and professional guidance. Additionally, the trusted nature of hospital pharmacies and the rising number of hospital visits contribute to their leading market share.

Competitive Landscape

Global Triamcinolone Ointment Chlorofluorocarbons Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Akorn Inc., Cosette Pharmaceuticals Inc., Glenmark Pharmaceuticals, Bristol Myers Squibb Company, Lupin Limited, Novartis International AG, Sun Pharmaceutical Industries Limited, Mylan N.V., Taro Pharmaceutical Industries, Lotus International, Delcor Asset Corporation, Fougera (Sandoz AG), Perrigo Company plc, and Other Prominent Players. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Global Triamcinolone Ointment Chlorofluorocarbons Market.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Triamcinolone Ointment Chlorofluorocarbons Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Global Triamcinolone Ointment Chlorofluorocarbons Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the Market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Triamcinolone Ointment Chlorofluorocarbons Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Efficacy in Treating Skin Conditions
      • 3.2.1.2. Rapid Symptom Relief
      • 3.2.1.3. Growing Availability and Accessibility
    • 3.2.2. Restraints
      • 3.2.2.1. Environmental Concerns
      • 3.2.2.2. Regulatory Restrictions
      • 3.2.2.3. Health Concerns
    • 3.2.3. Opportunities
      • 3.2.3.1. Development of CFC-Free Alternatives
      • 3.2.3.2. Innovation in Drug Delivery Systems
    • 3.2.4. Challenges
      • 3.2.4.1. Formulating Effective CFC-Free Alternatives
      • 3.2.4.2. Meeting Regulatory Requirements
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Triamcinolone Ointment Chlorofluorocarbons Market: Marketing Strategies

5. Global Triamcinolone Ointment Chlorofluorocarbons Market Overview

  • 5.1. Market Size & Forecast, 2019-2030
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share and Forecast
    • 5.2.1. By Type
      • 5.2.1.1. Triamcinolone Acetonide Ointment
      • 5.2.1.2. Triamcinolone Hexacetonide Ointment
      • 5.2.1.3. Triamcinolone Diacetate Ointment
      • 5.2.1.4. Triamcinolone Acetonide Chlorofluorocarbon (CFC) Propellant
      • 5.2.1.5. Others
    • 5.2.2. By Application
      • 5.2.2.1. Eczema
      • 5.2.2.2. Dermatitis
      • 5.2.2.3. Allergies
      • 5.2.2.4. Psoriasis
      • 5.2.2.5. Rashes
      • 5.2.2.6. Others
    • 5.2.3. By Distribution Channel
      • 5.2.3.1. Hospital Pharmacies
      • 5.2.3.2. Retail Pharmacies
      • 5.2.3.3. Online Pharmacies
      • 5.2.3.4. Others
    • 5.2.4. By Region
      • 5.2.4.1. North America
      • 5.2.4.2. Europe
      • 5.2.4.3. Asia Pacific (APAC)
      • 5.2.4.4. Latin America (LATAM)
      • 5.2.4.5. Middle East and Africa (MEA)

6. North America Triamcinolone Ointment Chlorofluorocarbons Market

  • 6.1. Market Size & Forecast, 2019-2030
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
      • 6.2.4.1. United States
      • 6.2.4.1.1. By Type
      • 6.2.4.1.2. By Application
      • 6.2.4.1.3. By Distribution Channel
      • 6.2.4.2. Canada
      • 6.2.4.2.1. By Type
      • 6.2.4.2.2. By Application
      • 6.2.4.2.3. By Distribution Channel

7. Europe Triamcinolone Ointment Chlorofluorocarbons Market

  • 7.1. Market Size & Forecast, 2019-2030
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
      • 7.2.4.1. Germany
      • 7.2.4.1.1. By Type
      • 7.2.4.1.2. By Application
      • 7.2.4.1.3. By Distribution Channel
      • 7.2.4.2. United Kingdom
      • 7.2.4.2.1. By Type
      • 7.2.4.2.2. By Application
      • 7.2.4.2.3. By Distribution Channel
      • 7.2.4.3. Italy
      • 7.2.4.3.1. By Type
      • 7.2.4.3.2. By Application
      • 7.2.4.3.3. By Distribution Channel
      • 7.2.4.4. France
      • 7.2.4.4.1. By Type
      • 7.2.4.4.2. By Application
      • 7.2.4.4.3. By Distribution Channel
      • 7.2.4.5. Spain
      • 7.2.4.5.1. By Type
      • 7.2.4.5.2. By Application
      • 7.2.4.5.3. By Distribution Channel
      • 7.2.4.6. Belgium
      • 7.2.4.6.1. By Type
      • 7.2.4.6.2. By Application
      • 7.2.4.6.3. By Distribution Channel
      • 7.2.4.7. Russia
      • 7.2.4.7.1. By Type
      • 7.2.4.7.2. By Application
      • 7.2.4.7.3. By Distribution Channel
      • 7.2.4.8. The Netherlands
      • 7.2.4.8.1. By Type
      • 7.2.4.8.2. By Application
      • 7.2.4.8.3. By Distribution Channel
      • 7.2.4.9. Rest of Europe
      • 7.2.4.9.1. By Type
      • 7.2.4.9.2. By Application
      • 7.2.4.9.3. By Distribution Channel

8. Asia Pacific Triamcinolone Ointment Chlorofluorocarbons Market

  • 8.1. Market Size & Forecast, 2019-2030
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. China
      • 8.2.4.1.1. By Type
      • 8.2.4.1.2. By Application
      • 8.2.4.1.3. By Distribution Channel
      • 8.2.4.2. India
      • 8.2.4.2.1. By Type
      • 8.2.4.2.2. By Application
      • 8.2.4.2.3. By Distribution Channel
      • 8.2.4.3. Japan
      • 8.2.4.3.1. By Type
      • 8.2.4.3.2. By Application
      • 8.2.4.3.3. By Distribution Channel
      • 8.2.4.4. South Korea
      • 8.2.4.4.1. By Type
      • 8.2.4.4.2. By Application
      • 8.2.4.4.3. By Distribution Channel
      • 8.2.4.5. Australia & New Zealand
      • 8.2.4.5.1. By Type
      • 8.2.4.5.2. By Application
      • 8.2.4.5.3. By Distribution Channel
      • 8.2.4.6. Indonesia
      • 8.2.4.6.1. By Type
      • 8.2.4.6.2. By Application
      • 8.2.4.6.3. By Distribution Channel
      • 8.2.4.7. Malaysia
      • 8.2.4.7.1. By Type
      • 8.2.4.7.2. By Application
      • 8.2.4.7.3. By Distribution Channel
      • 8.2.4.8. Singapore
      • 8.2.4.8.1. By Type
      • 8.2.4.8.2. By Application
      • 8.2.4.8.3. By Distribution Channel
      • 8.2.4.9. Vietnam
      • 8.2.4.9.1. By Type
      • 8.2.4.9.2. By Application
      • 8.2.4.9.3. By Distribution Channel
      • 8.2.4.10. Rest of APAC
      • 8.2.4.10.1. By Type
      • 8.2.4.10.2. By Application
      • 8.2.4.10.3. By Distribution Channel

9. Latin America Triamcinolone Ointment Chlorofluorocarbons Market

  • 9.1. Market Size & Forecast, 2019-2030
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
      • 9.2.4.1. Brazil
      • 9.2.4.1.1. By Type
      • 9.2.4.1.2. By Application
      • 9.2.4.1.3. By Distribution Channel
      • 9.2.4.2. Mexico
      • 9.2.4.2.1. By Type
      • 9.2.4.2.2. By Application
      • 9.2.4.2.3. By Distribution Channel
      • 9.2.4.3. Argentina
      • 9.2.4.3.1. By Type
      • 9.2.4.3.2. By Application
      • 9.2.4.3.3. By Distribution Channel
      • 9.2.4.4. Peru
      • 9.2.4.4.1. By Type
      • 9.2.4.4.2. By Application
      • 9.2.4.4.3. By Distribution Channel
      • 9.2.4.5. Rest of LATAM
      • 9.2.4.5.1. By Type
      • 9.2.4.5.2. By Application
      • 9.2.4.5.3. By Distribution Channel

10. Middle East & Africa Triamcinolone Ointment Chlorofluorocarbons Market

  • 10.1. Market Size & Forecast, 2019-2030
    • 10.1.1. By Value (USD Million)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
      • 10.2.4.1. Saudi Arabia
      • 10.2.4.1.1. By Type
      • 10.2.4.1.2. By Application
      • 10.2.4.1.3. By Distribution Channel
      • 10.2.4.2. UAE
      • 10.2.4.2.1. By Type
      • 10.2.4.2.2. By Application
      • 10.2.4.2.3. By Distribution Channel
      • 10.2.4.3. Qatar
      • 10.2.4.3.1. By Type
      • 10.2.4.3.2. By Application
      • 10.2.4.3.3. By Distribution Channel
      • 10.2.4.4. Kuwait
      • 10.2.4.4.1. By Type
      • 10.2.4.4.2. By Application
      • 10.2.4.4.3. By Distribution Channel
      • 10.2.4.5. South Africa
      • 10.2.4.5.1. By Type
      • 10.2.4.5.2. By Application
      • 10.2.4.5.3. By Distribution Channel
      • 10.2.4.6. Nigeria
      • 10.2.4.6.1. By Type
      • 10.2.4.6.2. By Application
      • 10.2.4.6.3. By Distribution Channel
      • 10.2.4.7. Algeria
      • 10.2.4.7.1. By Type
      • 10.2.4.7.2. By Application
      • 10.2.4.7.3. By Distribution Channel
      • 10.2.4.8. Rest of MEA
      • 10.2.4.8.1. By Type
      • 10.2.4.8.2. By Application
      • 10.2.4.8.3. By Distribution Channel

11. Competitive Landscape

  • 11.1. List of Key Players and Their Offerings
  • 11.2. Global Triamcinolone Ointment Chlorofluorocarbons Market Share Analysis, 2023
  • 11.3. Competitive Benchmarking, By Operating Parameters
  • 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

12. Impact of Escalating Geopolitical Tensions on Global Triamcinolone Ointment Chlorofluorocarbons Market

13. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 13.1. Akorn Inc.
  • 13.2. Cosette Pharmaceuticals Inc.
  • 13.3. Glenmark Pharmaceuticals
  • 13.4. Bristol Myers Squibb Company
  • 13.5. Lupin Limited
  • 13.6. Novartis International AG
  • 13.7. Sun Pharmaceutical Industries Limited
  • 13.8. Mylan N.V.
  • 13.9. Taro Pharmaceutical Industries
  • 13.10. Lotus International
  • 13.11. Delcor Asset Corporation
  • 13.12. Fougera (Sandoz AG)
  • 13.13. Perrigo Company plc
  • 13.14. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

  • 15.1. Qualitative Research
    • 15.1.1. Primary & Secondary Research
  • 15.2. Quantitative Research
  • 15.3. Market Breakdown & Data Triangulation
    • 15.3.1. Secondary Research
    • 15.3.2. Primary Research
  • 15.4. Breakdown of Primary Research Respondents, By Region
  • 15.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable